AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaInformation ScienceNamed GroupsHealth CareGeographicals
Hematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationLeukemia, Myeloid, AcuteGraft vs Host DiseaseTransplantation ConditioningLeukemia, MyeloidTransplantation, AutologousHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationLeukemiaRemission InductionRecurrenceTransplantation ChimeraTreatment OutcomeBone Marrow TransplantationStem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Leukemia EffectBusulfanVidarabineTissue DonorsMyeloablative AgonistsMyelodysplastic SyndromesAcute DiseaseGraft vs Tumor EffectCytarabinePrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibility TestingDisease-Free SurvivalGraft SurvivalRetrospective StudiesSurvival AnalysisHematopoietic Stem CellsLymphocyte TransfusionNeoplasm, ResidualSurvival RateCombined Modality TherapyImmunosuppressive AgentsMultiple MyelomaSalvage TherapyAntineoplastic Combined Chemotherapy Protocolsfms-Like Tyrosine Kinase 3SiblingsWhole-Body IrradiationPrognosisCord Blood Stem Cell TransplantationCytomegalovirus InfectionsMinor Histocompatibility AntigensLymphocyte DepletionAntilymphocyte SerumAntineoplastic AgentsTime FactorsLiver TransplantationFusion Proteins, bcr-ablHistocompatibilityBenzamidesVirus ActivationCytogenetic AnalysisMelphalanCyclophosphamideLeukemia, Lymphocytic, Chronic, B-CellAntigens, CD34Follow-Up StudiesBlast CrisisPyrimidinesGene Expression Regulation, LeukemicHepatic Veno-Occlusive DiseaseChimerismPiperazinesLeukemia, Myeloid, Accelerated PhaseT-LymphocytesBone MarrowHematopoietic Stem Cell MobilizationPrimary MyelofibrosisMesenchymal Stem Cell TransplantationCytomegalovirusAnemia, AplasticHLA AntigensLeukemia, Myelomonocytic, AcuteHematologic DiseasesCell TransplantationFlow CytometryGranulocyte Colony-Stimulating FactorCell DifferentiationKidney TransplantationDaunorubicinEmbryonic Stem CellsAntibodies, NeoplasmEtoposideBone Marrow CellsImmunophenotypingIdarubicinRisk FactorsHodgkin DiseaseImmunocompromised HostImmunosuppressionTransplantation ImmunologyLymphoproliferative DisordersFatal Outcome

No FAQ available that match "high risk of relapse patients with acute myeloid leukemia allogeneic stem cell transplantation"